CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Preventing Rebound-Associated Fractures after Discontinuation of Denosumab Therapy: A Position Statement from the Health Insurance Committee of the Korean Endocrine Society
Bu Kyung Kim, Chong Hwa Kim, Yong-Ki Min
Endocrinol Metab. 2021;36(4):909-911.   Published online August 27, 2021
DOI: https://doi.org/10.3803/EnM.2021.1193

Excel Download

Preventing Rebound-Associated Fractures after Discontinuation of Denosumab Therapy: A Position Statement from the Health Insurance Committee of the Korean Endocrine Society
Endocrinology and Metabolism. 2021;36(4):909-911   Crossref logo
Link1 Link2 Link3

Abstract #548 An Interesting Case of Rebound Associated Vertebral Fracture After Discontinuation of Denosumab
Endocrine Practice. 2018;24:133   Crossref logo
Link1 Link2

Rebound-associated vertebral fractures after discontinuation of denosumab—from clinic and biomechanics
Osteoporosis International. 2015;27(5):1917-1921   Crossref logo
Link1 Link2 Link3

Rebound-Associated Vertebral Fractures Two Months After a Missed Dose of Denosumab
Journal of the Endocrine Society. 2021;5(Supplement_1):A218-A218   Crossref logo
Link1 Link2

Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases
Journal of Bone and Mineral Research. 2017;32(6):1291-1296   Crossref logo
Link1 Link2

Second rebound-associated vertebral fractures after denosumab discontinuation
Archives of Osteoporosis. 2020;15(1):   Crossref logo
Link1 Link2 Link3

Magnetic resonance imaging has an advantage over conventional spine X-rays in the evaluation of rebound-associated vertebral fractures following denosumab discontinuation
Endocrine. 2020;69(3):516-518   Crossref logo
Link1 Link2 Link3

Symptomatic Rebound Hypercalcemia After Denosumab Discontinuation in a Pediatric Patient With Cherubism
Journal of the Endocrine Society. 2021;5(Supplement_1):A706-A707   Crossref logo
Link1 Link2

Rebound-associated vertebral fractures after discontinuation of denosumab for the treatment of maxillitis
Osteoporosis International. 2017;29(3):769-772   Crossref logo
Link1 Link2 Link3

Severe rebound effect and multiple fractures after denosumab discontinuation in patient with chronic kidney disease stage 5
Bone Reports. 2020;13:100562   Crossref logo
Link1 Link2